The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

Polymeric microspheres play a pivotal role in advancing high-potency therapeutics, offering controlled release capabilities. Significant progress in biotechnology and combinatorial chemistry has ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

Spray-dried protein microparticles without MoNi surfactant form paste-like materials (left), whereas those spray dried with MoNi surfactant form injectable suspensions that flow like liquids (right).

AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Type-3 New Drug Applications, focusing on new dosage forms, dominate the 505(b)(2) pathway approvals, with injectable formulations being the largest category. Stability and manufacturing consistency ...